Recent advance in prognostic indicators of primary central nervous system lymphoma
10.3760/cma.j.cn.1115354-20220428-00283
- VernacularTitle:原发性中枢神经系统淋巴瘤预后指标的研究现状
- Author:
Yuting GAO
1
;
Boyang LIU
;
Hua YOU
Author Information
1. 广州医科大学附属肿瘤医院内三科，广州 510095
- Keywords:
Primary central nervous system lymphoma;
Prognostic indicator;
Biomarker
- From:
Chinese Journal of Neuromedicine
2022;21(8):831-836
- CountryChina
- Language:Chinese
-
Abstract:
Primary central nervous system lymphoma (PCNSL) is a kind of highly aggressive and rare extranodal non-Hodgkin lymphoma, and the treatment effect and survival prognosis of these patients are still not satisfied. In recent years, domestic and foreign researchers have devoted themselves to find more effective prognostic indicators from clinical hematological indicators, as well as gene and protein levels, so as to guide the diagnosis and treatment of PCNSL more accurately in clinical practice and improve the prognosis of PCNSL patients to a greater extent. This paper provides a review of such studies by reviewing PubMed.
